window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 26, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Development

  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Development

    Hovione and Firstgene partner to accelerate gene therapy innovation for liver cancer

    Strategic collaboration combines advanced AAV-like particle technology with targeted oncology [...]

    May 7, 2025
  • Biologics & Biosimilars,Drug Development

    Molecular Devices unveils automated QPix FLEX system to transform microbial colony picking

    New benchtop platform boosts speed, sterility, and accuracy for microbiology [...]

    May 7, 2025
  • Clinical Trials,Drug Development,Market Access & Commercialization,Regulatory Affairs

    New study urges EU to overhaul regulatory landscape to remain competitive in pharma innovation

    Research from Bayes Business School and Merck KGaA identifies barriers [...]

    May 6, 2025
  • Biologics & Biosimilars,Cell & Gene Therapy,Drug Development

    Ethris secures €10 million EU4Health grant for ETH47 antiviral development

    Ethris GmbH has been awarded a €10 million grant from [...]

    May 6, 2025
  • Drug Development

    SOTIO’s SOT109 targets CDH17 in colorectal cancer: A new ADC contender emerges

    SOTIO’s lead candidate, SOT109, is generating buzz in the ADC [...]

    May 6, 2025
  • Artificial Intelligence,Drug Development

    EXCLUSIVE interview: How foundation models are redefining small molecule drug discovery

    As generative AI rapidly evolves, one of its most promising [...]

    May 5, 2025
  • Drug Development,Partnerships & Funding

    Er-Kim to distribute Nerlynx in CIS and Eastern Europe to improve HER2-positive breast cancer treatment access

    May 5, 2025
  • Cell & Gene Therapy,Drug Development

    Domain Therapeutics shares updates on immuno-oncology programs at AACR 2025

    May 1, 2025
  • CDMOs & Manufacturing,Drug Development,Partnerships & Funding

    BridgeBio sees strong launch for ATTR-CM drug Attruby and accelerates rare disease pipeline

    BridgeBio Pharma reported $36.7 million in US net revenue for [...]

    May 1, 2025
  • Drug Development

    Glen Clova Scientific relocates R&D operations to support pipeline expansion

    Glen Clova Scientific has moved its R&D operations to the [...]

    April 28, 2025
Previous252627Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Sartorius launches Eveo platform targeting cell therapy manufacturing bottlenecks
    Categories: CDMOs & Manufacturing, Cell & Gene Therapy, Manufacturing, Technology and platforms
  • One-carbon partners Tempus to support TH9619 development in solid tumours
    Categories: Clinical Development, Clinical Trials, Oncology, Partnerships & Funding, Technology and platforms
  • Strong scientists: PHARMExcel’s Margaret Irwin on clinical research careers and early stage trials
    Categories: Clinical Trials, Healthcare leadership, Women in Pharma
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top